• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌前哨淋巴结清扫术:1000多例患者的经验

Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.

作者信息

Weckermann Dorothea, Dorn Robert, Trefz M, Wagner Theodor, Wawroschek Friedhelm, Harzmann Rolf

机构信息

Department of Urology, Klinikum Augsburg, Augsburg, Germany.

出版信息

J Urol. 2007 Mar;177(3):916-20. doi: 10.1016/j.juro.2006.10.074.

DOI:10.1016/j.juro.2006.10.074
PMID:17296375
Abstract

PURPOSE

We determined the incidence of positive pelvic lymph nodes in men undergoing radical retropubic prostatectomy and describe the correlation with prostate specific antigen, histological grade and stage. We examined whether tumor cells are localized in the sentinel nodes only or also in other nonsentinel lymph nodes.

MATERIALS AND METHODS

A total of 1,055 men with prostate cancer underwent radio guided pelvic lymph node dissection and radical retropubic prostatectomy. In men with prostate specific antigen 20 ng/ml or less and biopsy Gleason score 7 or less only sentinel nodes were removed. In men with prostate specific antigen more than 20 ng/ml or Gleason score greater than 7 extended pelvic lymph node dissection was also performed.

RESULTS

Positive lymph nodes were found in 207 men (19.6%). In 63.3% of the men these lymph nodes were detected outside of the region of standard lymphadenectomy. The percent of patients with positive nodes was greater than predicted by currently used nomograms. The higher the preoperative prostate specific antigen, pathological stage and grade, the greater the percent of men with positive sentinel and nonsentinel lymph nodes (p<0.001).

CONCLUSIONS

When deciding on pelvic lymph node dissection, sentinel or extended lymphadenectomy should be performed since more than half of patients have positive nodes outside of the region of standard lymphadenectomy. In cases of positive sentinel nodes extended lymph node dissection should be performed since tumor cells are also detectable in nonsentinel lymph nodes.

摘要

目的

我们确定了接受耻骨后根治性前列腺切除术的男性盆腔淋巴结阳性的发生率,并描述了其与前列腺特异性抗原、组织学分级和分期的相关性。我们研究了肿瘤细胞是否仅局限于前哨淋巴结,还是也存在于其他非前哨淋巴结中。

材料与方法

共有1055例前列腺癌男性患者接受了放射性引导盆腔淋巴结清扫术和耻骨后根治性前列腺切除术。对于前列腺特异性抗原20 ng/ml及以下且活检Gleason评分7分及以下的男性患者,仅切除前哨淋巴结。对于前列腺特异性抗原超过20 ng/ml或Gleason评分大于7分的男性患者,还进行了扩大盆腔淋巴结清扫术。

结果

207例男性患者(19.6%)发现盆腔淋巴结阳性。在这些男性患者中,63.3%的阳性淋巴结是在标准淋巴结清扫区域以外检测到的。淋巴结阳性患者的比例高于目前使用的列线图预测值。术前前列腺特异性抗原、病理分期和分级越高,前哨和非前哨淋巴结阳性的男性患者比例越高(p<0.001)。

结论

在决定是否进行盆腔淋巴结清扫时,应进行前哨或扩大淋巴结清扫,因为超过一半的患者在标准淋巴结清扫区域以外存在阳性淋巴结。在前哨淋巴结阳性的情况下,应进行扩大淋巴结清扫,因为在非前哨淋巴结中也可检测到肿瘤细胞。

相似文献

1
Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.前列腺癌前哨淋巴结清扫术:1000多例患者的经验
J Urol. 2007 Mar;177(3):916-20. doi: 10.1016/j.juro.2006.10.074.
2
Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.前列腺癌患者中盆腔淋巴结阳性的发生率、前列腺特异性抗原(PSA)水平≤10 ng/mL且活检Gleason评分≤6的情况及其对根治性前列腺切除术后无PSA进展生存期的影响。
BJU Int. 2006 Jun;97(6):1173-8. doi: 10.1111/j.1464-410X.2006.06166.x.
3
Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.接受根治性前列腺切除术患者的扩大盆腔淋巴结清扫术:淋巴结转移发生率高。
J Urol. 2002 Apr;167(4):1681-6.
4
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.在前列腺特异性抗原时代,pTXNO前列腺癌的淋巴结清扫范围不影响前列腺癌的预后。
J Urol. 2005 Apr;173(4):1121-5. doi: 10.1097/01.ju.0000155533.93528.4c.
5
Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.局限性前列腺癌患者放射性同位素引导下前哨淋巴结清扫术:前100例结果
Eur J Surg Oncol. 2009 Jul;35(7):751-6. doi: 10.1016/j.ejso.2008.04.007. Epub 2008 Jun 6.
6
Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.通过扩大腹腔镜盆腔淋巴结清扫术与标准腹腔镜盆腔淋巴结清扫术检测前列腺癌中的淋巴结转移
Aktuelle Urol. 2010 Jan;41 Suppl 1:S10-4. doi: 10.1055/s-0029-1224663. Epub 2010 Jan 21.
7
Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?血清前列腺特异性抗原(PSA)<10ng/ml的前列腺癌患者在接受根治性前列腺切除术时是否需要进行盆腔淋巴结清扫?
Eur Urol. 2006 Aug;50(2):272-9. doi: 10.1016/j.eururo.2006.01.061. Epub 2006 Feb 28.
8
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.一种用于识别前列腺癌患者盆腔淋巴结转移风险降低的术前列线图。
J Urol. 2003 Nov;170(5):1798-803. doi: 10.1097/01.ju.0000091805.98960.13.
9
Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy?在进行确定性局部治疗之前,低风险前列腺癌患者是否需要进行盆腔淋巴结清扫?
Eur Urol. 2005 Jan;47(1):45-50; discussion 50-1. doi: 10.1016/j.eururo.2004.07.017.
10
Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.前列腺癌盆腔淋巴结清扫模式的变化:CaPSURE研究结果
J Urol. 2006 Oct;176(4 Pt 1):1382-6. doi: 10.1016/j.juro.2006.06.001.

引用本文的文献

1
Indocyanine green fluorescence in pelvic lymph node dissection during laparoscopic radical prostatectomy: a randomized controlled trial.腹腔镜根治性前列腺切除术中盆腔淋巴结清扫的吲哚菁绿荧光:一项随机对照试验
Updates Surg. 2025 Jul 16. doi: 10.1007/s13304-025-02330-x.
2
Diagnostic Accuracy of Indocyanine Green-stained Sentinel Lymph Nodes in Prostate Cancer Patients: A Systematic Review and Meta-analysis.吲哚菁绿染色前哨淋巴结在前列腺癌患者中的诊断准确性:一项系统评价和荟萃分析
Eur Urol Open Sci. 2025 Feb 21;74:34-43. doi: 10.1016/j.euros.2025.02.002. eCollection 2025 Apr.
3
Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives.
癌症成像与荧光引导手术中的双标记小肽:进展与未来展望
Pharmaceuticals (Basel). 2025 Jan 22;18(2):143. doi: 10.3390/ph18020143.
4
Progress of fluorescence imaging in lymph node dissection surgery for prostate and bladder cancer.前列腺癌和膀胱癌淋巴结清扫手术中荧光成像的进展
Front Oncol. 2024 Oct 4;14:1395284. doi: 10.3389/fonc.2024.1395284. eCollection 2024.
5
Fluorescence-guided extended pelvic lymphadenectomy during robotic radical prostatectomy.荧光引导下的机器人辅助根治性前列腺切除术时的扩大盆腔淋巴结清扫术。
J Robot Surg. 2023 Jun;17(3):885-890. doi: 10.1007/s11701-022-01480-z. Epub 2022 Nov 3.
6
Tc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients.Tc-PSMA 靶向机器人辅助放射性引导手术在根治性前列腺切除术和前列腺癌患者的扩大淋巴结清扫术中的应用。
Ann Nucl Med. 2022 Jul;36(7):597-609. doi: 10.1007/s12149-022-01741-9. Epub 2022 Apr 15.
7
A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer.一类新型基于PSMA-617的杂交分子用于前列腺癌的术前成像和术中荧光导航
Pharmaceuticals (Basel). 2022 Feb 22;15(3):267. doi: 10.3390/ph15030267.
8
Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.合理设计连接子以加速排泄并减少肽模拟 PSMA 靶向杂合分子的背景摄取。
J Nucl Med. 2021 Oct;62(10):1461-1467. doi: 10.2967/jnumed.120.248443. Epub 2021 Mar 19.
9
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging.源自PSMA-11的杂交分子PSMA-914通过术前PET/CT和术中荧光成像特异性识别前列腺癌。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2057-2058. doi: 10.1007/s00259-020-05184-0. Epub 2021 Jan 23.
10
Applied anatomy of pelvic lymph nodes and its clinical significance for prostate cancer:a single-center cadaveric study.盆腔淋巴结的应用解剖及其在前列腺癌中的临床意义:一项单中心尸体研究。
BMC Cancer. 2020 Apr 16;20(1):330. doi: 10.1186/s12885-020-06833-1.